A National, Prospective, Randomized, Open Label Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin vs IV Ceftriaxone + IV Azithromycin Followed by PO Amoxicilline/Clavulanate and PO Clarithromycin in Subjects With Community-Acquired Pneumonia.

Trial Profile

A National, Prospective, Randomized, Open Label Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin vs IV Ceftriaxone + IV Azithromycin Followed by PO Amoxicilline/Clavulanate and PO Clarithromycin in Subjects With Community-Acquired Pneumonia.

Completed
Phase of Trial: Phase III

Latest Information Update: 28 Oct 2013

At a glance

  • Drugs Amoxicillin/clavulanic acid; Azithromycin; Ceftriaxone; Clarithromycin; Moxifloxacin; Moxifloxacin
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Sponsors Bayer
  • Most Recent Events

    • 16 Jul 2010 Actual end date (Jun 2009) added as reported by ClinicalTrials.gov.
    • 16 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 12 Jun 2009 Planned end date changed from Feb 2009 to Feb 2010 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top